Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $264 thousand versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.